TY - JOUR
T1 - Clinical practice recommendations for kidney involvement in tuberous sclerosis complex
T2 - a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group
AU - Mekahli, Djalila
AU - Müller, Roman Ulrich
AU - Marlais, Matko
AU - Wlodkowski, Tanja
AU - Haeberle, Stefanie
AU - de Argumedo, Marta López
AU - Bergmann, Carsten
AU - Breysem, Luc
AU - Fladrowski, Carla
AU - Henske, Elizabeth P.
AU - Janssens, Peter
AU - Jouret, François
AU - Kingswood, John Christopher
AU - Lattouf, Jean Baptiste
AU - Lilien, Marc
AU - Maleux, Geert
AU - Rozenberg, Micaela
AU - Siemer, Stefan
AU - Devuyst, Olivier
AU - Schaefer, Franz
AU - Kwiatkowski, David J.
AU - Rouvière, Olivier
AU - Bissler, John
N1 - © 2024. Springer Nature Limited.
PY - 2024/6
Y1 - 2024/6
N2 - Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by the presence of proliferative lesions throughout the body. Management of TSC is challenging because patients have a multifaceted systemic illness with prominent neurological and developmental impact as well as potentially severe kidney, heart and lung phenotypes; however, every organ system can be involved. Adequate care for patients with TSC requires a coordinated effort involving a multidisciplinary team of clinicians and support staff. This clinical practice recommendation was developed by nephrologists, urologists, paediatric radiologists, interventional radiologists, geneticists, pathologists, and patient and family group representatives, with a focus on TSC-associated kidney manifestations. Careful monitoring of kidney function and assessment of kidney structural lesions by imaging enable early interventions that can preserve kidney function through targeted approaches. Here, we summarize the current evidence and present recommendations for the multidisciplinary management of kidney involvement in TSC.
AB - Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by the presence of proliferative lesions throughout the body. Management of TSC is challenging because patients have a multifaceted systemic illness with prominent neurological and developmental impact as well as potentially severe kidney, heart and lung phenotypes; however, every organ system can be involved. Adequate care for patients with TSC requires a coordinated effort involving a multidisciplinary team of clinicians and support staff. This clinical practice recommendation was developed by nephrologists, urologists, paediatric radiologists, interventional radiologists, geneticists, pathologists, and patient and family group representatives, with a focus on TSC-associated kidney manifestations. Careful monitoring of kidney function and assessment of kidney structural lesions by imaging enable early interventions that can preserve kidney function through targeted approaches. Here, we summarize the current evidence and present recommendations for the multidisciplinary management of kidney involvement in TSC.
KW - Tuberous Sclerosis Complex
KW - ERKNet
KW - Autosomal dominant structural kidney disorder
KW - ERA
UR - http://www.scopus.com/inward/record.url?scp=85186575428&partnerID=8YFLogxK
U2 - 10.1038/s41581-024-00818-0
DO - 10.1038/s41581-024-00818-0
M3 - Article
C2 - 38443710
AN - SCOPUS:85186575428
SN - 1759-5061
VL - 20
SP - 402
EP - 420
JO - Nature Reviews Nephrology
JF - Nature Reviews Nephrology
IS - 6
ER -